Phase 4CompletedAge-related condition
A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration (DEUTERON)
An Open-label, Non-randomized, Multi-center, Phase 4 Pharmacokinetic Study to Evaluate the Systemic Exposure After Bilateral Intravitreal Administration of High Dose (8 mg) Aflibercept in Adults With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration
- Sponsor
- Bayer (Industry)
- Enrollment
- 51 enrolled
- Conditions
- Diabetic Macular Edema; Neovascular Age-related Macular Degeneration
- Interventions
- Aflibercept (BAY86-5321, Eylea)
- Ages
- adults, older adults
- Registry
- NCT06591598, CTIS2024-511665-11-00
Full record on ClinicalTrials.gov
From the registry
Researchers are looking for a better way to treat participants who have diabetic macular edema (DME) or neovascular age-related macular degeneration (nAMD). DME is a diabetes-related eye disorder. In DME, the macula swells up due to fluid leakage from damaged blood vessels, resulting in vision problems. DME is a leading cause of vision loss in working age adults. nAMD is an eye disorder that causes vision loss due to the growth of abnormal blood vessels that leak blood or retinal fluid into the macula (the central part of the retina). nAMD is a leading cause of vision loss for people aged 50 and older. The study treatment Aflibercept (also called BAY 86-5321) is a drug that blocks a protein called vascular endothelial growth factor (VEGF) which causes abnormal growth and leakage of blood vessels at the back of the eye. The main purpose of this study is to to collect more information on the blood levels of aflibercept when 8 mg aflibercept is injected in both eyes of participants with DME or nAMD. For this, the researchers will analyze Maximum observed concentration (Cmax): the…
Primary outcomes
- Maximum Observed Concentration (Cmax) of Free Aflibercept
History
Results first posted
Last registry update
Primary completion
Registered
Started